Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,638,779
+$6,922,416 QoQ
Shares Held
202,056
+11.2% QoQ
Ownership
0.694%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 211 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. ANAB ranks #48 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in ANAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,638,779 | 202,056 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,716,363 | 121,103 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $6,011,809 | 124,006 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,297,700 | 42,381 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,846,460 | 83,174 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $396,633 | 21,336 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $308,332 | 23,288 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,718,210 | 51,290 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $473,884 | 18,910 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $452,087 | 20,075 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $208,158 | 9,718 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $179,993 | 10,022 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $204,762 | 10,067 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $567,023 | 18,297 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $467,164 | 18,313 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $384,662 | 18,949 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $413,107 | 16,698 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $667,686 | 19,214 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $576,435 | 21,255 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $520,751 | 20,083 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $404,127 | 18,753 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $623,196 | 28,986 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $389,973 | 26,439 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $607,847 | 27,209 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $427,573 | 30,260 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||